Cytoplasmic survivin staining intensity was significantly associated with biochemical relapse (earlier PSA recurrence) (p = 0.0101, Fig. 4A), but not with onset of metastatic disease (p = 0.18), and cancer-related survival (p = 0.08). Here, BIRC5 is linked to cancer.